Carregant...
CYP1B1 as a therapeutic target in cardio-oncology
Cardiovascular complications have been frequently reported in cancer patients and survivors, mainly because of various cardiotoxic cancer treatments. Despite the known cardiovascular toxic effects of these treatments, they are still clinically used because of their effectiveness as anti-cancer agent...
Guardat en:
| Publicat a: | Clin Sci (Lond) |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Portland Press Ltd.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7672255/ https://ncbi.nlm.nih.gov/pubmed/33185690 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/CS20200310 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|